Meta-Analysis Finds ADHD Drugs Not Linked to Risk of Cardiovascular Disease — Still, authors say more research needed to rule out risk in certain groups
Use of medications for attention deficit-hyperactivity disorder (ADHD) was not associated with increased cardiovascular disease (CVD) risk, a systematic review and meta-analysis of 19 studies showed, although the researchers cautioned that a modest risk increase could not be completely ruled out.
Other Articles in this Edition
Adderall shortage raises questions about widespread dependency on the drug
How to Tell the Difference Between Regular Distraction and A.D.H.D.
Concerns grow over online ADHD diagnoses
Simulated driving program reduces crash risk for teens with ADHD in small study
NIH researchers unlock pattern of gene activity for ADHD
Benzodiazepine exposure in pregnancy does not up risk for ADHD, autism
Methylphenidate Improves Functionality in Preschoolers With ADHD
Young Motherhood, Child ADHD Link Explained
Teens and young adults are self-diagnosing mental illness on TikTok. What could go wrong?
Amid the Adderall Shortage, People With A.D.H.D. Face Withdrawal and Despair